glp-1 drugs and cancer may reduce the risk of progressing, study suggests Do GLP-1 drugs cause cancer?

Sacai H, Sasaki-Hamada S, Sugiyama A, et al

Glucagon-like peptide-1 (GLP-1) is a GI peptide that stimulates insulin secretion (similar to sulfonylureas)

They need structure, visibility, and data-driven controls

Across more than a decade of accumulated research, no signal of causal association has held up under rigorous analysis

KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use Findings Key Takeaways With the Trump administration recently announcing several high-profile prescription drug pricing deals, the latest polling from KFF suggests that few think it is likely the Trump administrations actions will lower their prescription drug costs, but his base remains more positive

This steady and gradual decline in body weight is a positive indicator that the medication is working effectively